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A B S T R A C T
Early-life adversity is associated with increased risk for substance abuse in later life, with women more likely to
report past and current stress as a mediating factor in their substance use and relapse as compared to men.
Preclinical models of neonatal and peri-adolescent (early through late adolescence) stress all support a direct
relationship between experiences of early-life adversity and adult substance-related behaviors, and provide
valuable information regarding the underlying neurobiology. This review will provide an overview of these
animal models and how these paradigms alter drug and alcohol consumption and/or seeking in male and female
adults. An introduction to the corticotropin-releasing factor (CRF) and serotonin systems, their development and
their interactions at the level of the dorsal raphe will be provided, illustrating how this particular stress system is
sexually dimorphic, and is well positioned to be affected by stressors early in development and throughout
maturation. A model for CRF-serotonin interactions in the dorsal raphe and how these influence dopaminergic
activity within the nucleus accumbens and subsequent reward-associated behaviors will be provided, and al-
terations to the activity of this system following early-life adversity will be identified. Overall, converging
findings suggest that early-life adversity has long-term effects on the functioning of the CRF-serotonin system,
highlighting a potentially important and targetable mediator linking stress to addiction. Future work should
focus on identifying the exact mechanisms that promote long-term changes to the expression and activity of CRF
receptors in the dorsal raphe. Moreover, it is important to clarify whether similar neurobiological mechanisms
exist for males and females, given the sexual dimorphism both in CRF receptors and serotonin indices in the
dorsal raphe and in the behavioral outcomes of early-life adversity.
1. Introduction
Neglect as well as physical and sexual abuse of minors are highly
prevalent in the United States, with approximately 676,000 child vic-
tims and 3.5 million child protective services investigations in 2016
(U.S. Department of Health and Human Services, 2018). Stressful ex-
periences during childhood and adolescence, a time when brain regions
important for executive function and reward processing are still de-
veloping, can have long lasting influences into adulthood. The goal of
the current review is to provide a working neurobiological model de-
scribing how early-life adversity may influence substance use during
adulthood, which will inform future directions in the field. To do so, we
will introduce the problem of early-life adversity and the influence it
has on substance use later in life, discuss corticotropin-releasing factor
(CRF) and serotonin as major players in early-life stress outcomes in
adulthood, and give an overview of the development of both CRF and
serotonin systems and associated sex differences that may increase
vulnerability to the effects of early-life adversity. Finally, we will de-
scribe how these systems interact and are influenced by early-life ad-
versity to increase substance use susceptibility later in life.
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2. The problem of early-life adversity and substance use
Childhood, peri-adolescence (early through late adolescence in-
cluding puberty), and early adulthood mark a particularly vulnerable
time to the effects of stress. Exposure to stress early in life may be
particularly deleterious on behavioral outcomes in adulthood given the
correspondence these time periods have to brain development (for re-
view see Kolb and Gibb, 2011; Kolb et al., 2013). In humans, early-life
adversity arising from physical, emotional, and sexual abuse correlates
with an increased risk of substance use and other mental health dis-
orders including anxiety disorders, major depressive disorder, and
schizophrenia (Espejo et al., 2007; Heim et al., 2008; Copeland et al.,
2013; Merrick et al., 2017; Seidenfaden et al., 2017). Children exposed
to early-life adversity through abuse and/or neglect also have increased
risk of drug use, relapse following drug abstinence, and overall in-
creased prevalence of substance use disorders during adulthood
(Messina et al., 2008; Van Dam et al., 2014; Teixeira et al., 2017).
Adolescents from a family with a history of substance use disorders
have an increased likelihood of experiencing more frequent and severe
stressors, and initiation of substance use is indirectly influenced by
stress exposure; indicative of a cycle of stress and substance use
(Charles et al., 2015a; b). Adults that report childhood sexual abuse also
report earlier initiation of and increased use of illicit drugs (Harrison
et al., 1989; Ompad et al., 2005; Nelson et al., 2006). Furthermore,
children exposed to two or more stressful life events have an increased
risk for developing alcohol dependence compared to children that did
not experience any stressful life events (Pilowsky et al., 2009), with
stress likely being a greater mediating factor in women compared to in
men (Simpson and Miller, 2002; Widom et al., 2006; Enoch, 2011).
Similarly, in women, emotional abuse has a stronger association with
age of first alcohol use and severity of substance abuse compared to
men (Hyman et al., 2006), and childhood emotional abuse is associated
with cocaine relapse in women but not in men (Hyman et al., 2008).
Combined, these findings imply that trauma or stress early in devel-
opment may play a more prominent role in promoting adult drug-
taking behaviors in women. These data suggest that women have a
higher likelihood for a stress-induced trajectory to drug taking, re-
sulting in a more rapid transition from drug taking to dependence and
greater propensity for relapse compared to men (Hudson and Stamp,
2011; Becker et al., 2012). Overall, it appears that exposure to adverse
experiences early in life increases risk of substance use during adult-
hood, but it is important to note that not all children exposed to early-
life adversity go on to develop a substance use disorder, arguing for the
importance and contribution of both genetics, epigenetics, and the in-
fluence of other environmental factors that may contribute to these
individual differences.
3. Effects of early life adversity on reward processes and drug
responses in preclinical models
Three main types of paradigms have been used in rodents to model
early-life adversity and directly test the impact of early-life stress on
drug-related behaviors. These include social isolation/social disruption,
social defeat stress, and maternal separation, which differ in the de-
velopmental period of stress exposure (Fig. 1, see figure legend for age
ranges corresponding to weaning, peri-adolescence, adolescence and
puberty). Social isolation/disruption from weaning to either mid-ado-
lescence or up to adulthood (Fig. 1) interrupts the development of play
behavior and results in aggression, anxiety, and hyperactivity during
adulthood (Hall, 1998; Varlinskaya et al., 1999; Heidbreder et al.,
2000; Lukkes et al., 2009c; Watt et al., 2017). Social isolation/disrup-
tion during periods of development corresponding to pre-pubescence
and adolescence results in a sensitized response to amphetamine
(McCormick et al., 2005; Mathews et al., 2008), enhanced acquisition
of cocaine self-administration at low doses, and decreased acquisition at
higher doses in adulthood (Schenk et al., 1987; Boyle et al., 1991;
Phillips et al., 1994; Howes et al., 2000; Kosten et al., 2000, 2004;
2006; Yajie et al., 2005; Gipson et al., 2011; Baarendse et al., 2014).
Further, social isolation/disruption during a more discreet period of
development from postnatal day (PND) 21–42 (weaning to mid-ado-
lescence) followed by weeks of re-socialization results in increased
motivation for cocaine while not altering extinction responding, or cue-
cocaine- or yohimbine-induced reinstatement of cocaine seeking during
adulthood (Baarendse et al., 2014). Alterations in drug-taking behavior
are not specific to stimulants, given that social isolation/disruption
from weaning to early adulthood also increases ethanol consumption
and self-administration during adulthood in both rats and mice (McCool
and Chappell, 2009; Lopez et al., 2011). Increased sensitivity to opiates
is often reported following post-weaning social isolation, but findings
are not always consistent among the different paradigms (Neisewander
et al., 2013). For example, social isolation increases morphine and su-
fentanil self-administration but decreases morphine or heroin pre-
ferences in conditioned place preference tasks (Alexander et al., 1978;
Weinhold et al., 1993; Schenk et al., 1983, 1985; Kennedy et al., 2011).
Together, these studies indicate that social isolation/disruption fol-
lowing weaning typically results in increased self-administration of a
variety of drug classes and often enhances other indices of substance-
associated behaviors during adulthood.
Social defeat involves an imbalance of power between a dominant
and subordinate animal. Social defeat stress can be used as a model of
peer victimization and bullying frequently experienced during child-
hood and adolescence (Fig. 1) (Bjorkqvist, 2001; Watt et al., 2009;
Burke et al., 2017). This type of stress during the adolescent period
effectively results in heightened novelty seeking and risk taking in
adulthood (Watt et al., 2009) along with executive function deficits
(Novick et al., 2013; Watt et al., 2017). Social defeat in pre-adolescence
(e.g., PND 14–38) increases conditioned place preferences for cocaine
and MDMA, and enhances alcohol consumption and motivation to ad-
minister alcohol in adulthood (Lo Iacono et al., 2016; Garcia-Pardo
et al., 2015; Rodriguez-Arias et al., 2015). Similarly, social defeat re-
stricted to mid-adolescence (PND 35–44) results in augmented loco-
motion following a low dose of amphetamine and increased ampheta-
mine conditioned place preference during adulthood (Burke et al.,
2011, 2013). Adolescent social defeat also increased the percentage of
rats that voluntarily acquired the task of cocaine self-administration
acquisition, the motivation to lever press for cocaine as measured using
a progressive ratio schedule, and the amount of cocaine consumed
when given unlimited access during a 24 h binge later in life (Burke and
Miczek, 2015; Burke et al., 2016). Furthermore, a metric used to de-
termine how stressful the social defeat was during adolescence in in-
dividual rats was positively correlated with the amount of cocaine
consumed under progressive ratio and unlimited access schedules ap-
proximately 40 days later in adulthood (Burke and Miczek, 2015; Burke
et al., 2016). Thus, similar to the social isolation model, social defeat
stress applied either prior to or during adolescence effectively enhances
drug and alcohol responding in adulthood, suggestive of long-term ef-
fects of stress on reward-associated neural systems.
Maternal separation is used to describe a variety of neonatal para-
digms during which the pups are separated from the mother for various
lengths of time (for review of methodologies see Kosten et al., 2012;
Nylander and Roman, 2013; Tractenberg et al., 2016). Studies using
this paradigm often have inconsistent timing and lengths of separation
(i.e., methodologies), making comparisons difficult. Despite these
shortfalls, there are remarkable consistencies regarding the influence
that prolonged (three or more hrs) daily maternal separation has on
later drug reactivity and responding for drugs in adulthood. Maternal
separation from PND 1–14 increases the rewarding effects of acute
amphetamine exposure during adulthood, as measured by a decrease in
intracranial self-stimulation current threshold (Der-Avakian and
Markou, 2010). Similar to findings following social isolation/social
disruption, maternal separation results in greater methamphetamine
self-administered and earlier acquisition while not altering extinction
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or cue-induced reinstatement (Moffett et al., 2006; Lewis et al., 2013,
2106). Exposure to maternal separation also has effects on alcohol and
opiate intake and preferences during adulthood. To illustrate, male rats
exposed to maternal separation exhibit increased self-administered al-
cohol binge drinking, corresponding to increased impulsivity and in-
creased ethanol preference (Huot et al., 2001; Ploj et al., 2003;
Jaworski et al., 2005; Gondre-Lewis et al., 2016), heightened morphine
conditioned place preference and increased morphine self-administra-
tion (Michaels and Holtzman, 2008; Vazquez et al., 2005, 2006; 2007).
Overall, these findings indicate that the long-lasting effects of early-
life adversity may be conserved across various drug classes. Collectively
these studies also demonstrate that social isolation/social disruption,
social defeat, and maternal separation have similar outcomes for drug-
related behaviors in adulthood despite their different methodologies
and the variety of developmental time periods in which these stressors
are experienced (Fig. 1). Interestingly, similar outcomes are noted with
prenatal stressors (Kippin et al., 2015; Reynaert et al., 2015). This
suggests that there may not be a critical period in development by
which stress has negative consequences for later substance use, and
instead, any period of development early in life is a sensitive time for
the effects of stress. However, due to the different stages of brain de-
velopment affected by each specific early-life adversity model (Fig. 1),
it is likely that the underlying neural substrates promoting enhanced
drug taking or preferences differ among the developmental stressors
(discussed further in Section 6).
Despite sex differences in the prevalence of mental health disorders
including anxiety disorders, major depressive disorder, and substance
use disorders (Sinha et al., 2007; Ter Horst et al., 2009; Hudson and
Stamp, 2011; Becker et al., 2012; Valentino et al., 2013), little work in
rodent studies has been done to characterize the influence of stress
during development in both males and females on outcomes in adult-
hood. Furthermore, the differential trajectory of brain development
(Becker et al., 2007; Ball et al., 2014) urges for further investigation in
both males and females. Studies that have probed for potential sex
differences in the effects of early-life adversity on later drug or alcohol
measures in rodents are surprising. Contrary to the findings discussed
above (Simpson and Miller, 2002; Widom et al., 2006; Enoch, 2011),
where early-life adversity has a greater impact on later alcohol use in
women, rodent studies either fail to find a sex difference or show that
female rodents are not affected by the early-life stressor when alcohol
preference or intake is measured in adulthood (e.g. Roman et al., 2004;
Gustafsson et al., 2005; Lopez et al., 2011). It is possible that the effects
of early-life adversity in female rodents are more apparent for responses
to stimulants. For example, female rats briefly handled during week two
of life show increased self-administration of cocaine during adulthood,
whereas males do not (Flagel et al., 2003). Likewise, social instability
stress from PND 33–48 results in increased nicotine-induced locomotion
in adult female but not male rats (McCormick et al., 2005). However,
there are just as many instances where stimulant responses in males and
females during adulthood are similar following early-life adversity. For
example, maternal separation for an hour a day from PND 2–12 in-
creases responding for cocaine during extinction and cue-induced re-
instatement similarly in both male and female rats (Lynch et al., 2005).
Also, social instability of rats from PND 30–45 increases amphetamine-
induced locomotion equally among both sexes (Mathews et al., 2008).
Further work is needed to determine whether animal models suffi-
ciently model human sex differences in the impact of early-life adver-
sity on later substance use, and to determine whether any sex differ-
ences in stress and drug responsivity are due to the activational rather
than organizational effects of gonadal hormones (for review see Ball
et al., 2014).
The exact neurobiological mechanisms through which early-life
adversity leads to increased substance use in adulthood remain to be
elucidated. Numerous preclinical studies have shown that stress ex-
perienced in early-life results in long term functional alterations in the
mesocorticolimbic system and corresponding changes in reward pro-
cessing, particularly in enhancing responses to a range of abused sub-
stances (see Moffett et al., 2006; Miczek et al., 2008; Enoch, 2011;
Bardo et al., 2013; Delavari et al., 2016; Watt et al., 2017 for reviews).
Not surprisingly, many of the observed neurobiological effects involve
direct changes to dopaminergic signaling in the nucleus accumbens
(NAc), along with modifications to activity of other stress-responsive
factors that impinge upon accumbal function either directly or in-
directly, including CRF, GABAergic, glutamatergic, noradrenergic,
neurotrophic, opioid, and glucocorticoid systems (see Fone and Porkess,
2008; Sinha, 2008; Bardo et al., 2013; Mantsch et al., 2014; Jawahar
et al., 2015; Watt et al., 2017). Here, we will focus on a neural system
characterized by CRF-serotonin interactions that is upstream of the
dopaminergic mesocorticolimbic pathways, and we will examine the
emerging body of converging evidence suggesting that early life stress
has long-term effects on the functioning of the CRF-serotonin system.
4. Corticotropin-releasing factor (CRF) and serotonin interactions
mediating stress and reward reponses
Topographically organized, functional subsets of serotonergic neu-
rons of the dorsal raphe nucleus (dRN) are often associated with
mediating the negative consequences of early life adversity (Lowry
et al., 2008; Lukkes et al., 2009c; Burke et al., 2017) and also with drug-
associated behaviors (Vuong et al., 2010; Valentino et al., 2010). Si-
milarly, the actions of the stress-related neuropeptide CRF in the brain
have been implicated in early life adversity and addiction (Sinha, 2008;
Lukkes et al., 2009c; Koob et al., 2013). The dRN is a major site for CRF
interactions with a distributed serotonergic system, and the neurons of
Fig. 1. Timeline of neural development of the corti-
cotropin-releasing factor (CRF) and dorsal raphe nu-
cleus (dRN) serotonin systems in relation to the time
periods in which different stress paradigms are em-
ployed. Note that peri-adolescence for the rat is con-
sidered to begin at weaning (PND 21), encompassing
adolescence from PND 32 to PND 56–60 (although
adolescence may begin later in males) (Sengupta,
2013). Rats are thought to attain puberty by PND 50
(Sengupta, 2013). The time period in which each
early-life stress paradigm is indicated represents the
age ranges used by a majority of studies described
here, although a number of social isolation/disruption
or social defeat studies use more specific age ranges to restrict stress to discrete developmental periods, as detailed in the text. CRF expression in the central nucleus
of the amygdala (CeA; gray bar) is thought to increase over development, whereas CRF receptor expression (solid lines) in most brain regions peaks very early in
postnatal development. As indicated by the bifurcating black solid line, CRF receptor expression shows a second developmental change over puberty, with either a
decrease or increase in expression dependent on brain region studied, sex of individual and receptor (CRF1 or CRF2). The expression of tryptophan hydroxylase 2
(TPH2) in the dRN (dashed lines), as a measure of serotonin levels/neurons, increases over development in males, but peaks around PND42 in females and then
declines to adulthood. See text for citations.
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the dRN receive CRF projections likely from specific subregions of the
central nucleus of the amygdala (CeA) and bed nucleus of the stria
terminalis (BNST) (Gray, 1993; Fox and Lowry, 2013). Both local GA-
BAergic interneurons and serotonergic projection neurons of the dRN
subregions are targeted by CRF terminals and both neuronal types
possess CRF1 and CRF2 receptors (Day et al., 2004; Waselus et al., 2005;
Lukkes et al., 2011, Fig. 2). Both serotonin and CRF are implicated in
behavioral and emotional states that are risk factors for substance use
and dependence, such as anxiety, dysphoria, and impulsivity (Lowry
and Moore, 2006; Lukkes et al., 2009c; Valentino et al., 2010;
Cunningham and Anastasio, 2014; Muller and Homberg, 2015; Ouzir
and Errami, 2016; Roberto et al., 2017). Therefore it is not surprising
that CRF-dRN interactions and resultant serotonergic output to the
extended limbic system have gained attention as a potential important
mediator linking stress to addiction (e.g. Vuong et al., 2010; Scholl
et al., 2010; Valentino et al., 2010).
Generally, findings from electrophysiological studies within the
dRN and measures of serotonin release in limbic structures following
global dRN manipulation align to conclude that CRF1 receptor activity
decreases, whereas CRF2 receptor activity increases, dRN serotonergic
neuronal activity and serotonin release (Kirby et al., 2000; Amat et al.,
2004; Pernar et al., 2004; Forster et al., 2008; Lukkes et al., 2008,
2009a; Waselus et al., 2009). Although both receptor types are localized
to serotonergic and GABAergic neurons in the dRN, the opposing effects
of CRF1 vs CRF2 receptors on serotonergic output from this region may
reflect predominant excitation of GABAergic neurons in the dRN by
CRF1 receptors and activation of serotonergic neurons by local CRF2
receptors (Fig. 2). Of relevance, CRF2 receptors appear to be equally
localized to serotonergic and GABAergic neurons in the caudal dRN but
are almost exclusively localized to serotonergic neurons in the rostral
dRN (Day et al., 2004), which may account for a predominant increase
in serotonin output from the dRN when CRF2 receptors are globally
activated by pharmacological manipulation of the dRN. While CRF1
receptors in other brain regions are more often associated with stress
responses and fear or anxiety-like behaviors in preclinical models
(Heinrichs et al., 1997; Skutella et al., 1998; Timpl et al., 1998; Muller
et al., 2003; Gehlert et al., 2005), there appears to be a more important
role for CRF2 receptors specifically in the dRN in mediating adaptive
and maladaptive stress responses (Lukkes et al., 2009c; Waselus et al.,
2009; Wood et al., 2013). For example, activation of CRF2, but not
CRF1, receptors throughout the dRN results in increased serotonin re-
lease in various amygdala subregions, prefrontal cortex and NAc (Amat
et al., 2004; Forster et al., 2008; Lukkes et al., 2008; Scholl et al., 2010),
and pharmacological blockade of CRF2 receptors in the dRN reduces
fear or anxiety-like behaviors in a variety of animal models (Takahashi
et al., 2001; Hammack et al., 2003; Cooper and Huhman, 2007; Vuong
et al., 2010; Lukkes et al., 2009b; Bledsoe et al., 2011). Interestingly,
CRF1 and CRF2 receptors differentially respond to stress (Waselus et al.,
2009; Wood et al., 2013) which may account for the prominent role of
dRN CRF2 receptors in stress-related outcomes. Within the dRN, CRF2
receptors are trafficked to the neuronal membrane while CRF1 receptors
are internalized in response to an acute swim stress or chronic social
stress (Waselus et al., 2009; Wood et al., 2013). These molecular
changes manifest in stress-induced alterations in dRN serotonergic
neuronal firing patterns that shift from CRF1-mediated inhibition to
CRF2-mediated excitation, accompanied by a change in cognitive per-
formance that is dependent upon increased cortical serotonin trans-
mission (Waselus et al., 2009; Wood et al., 2013; Snyder et al., 2015).
Overall, the CRF2 receptor in the dRN plays an important role in fa-
cilitating serotonergic transmission in the limbic system, which appears
to become more pronounced in response to both acute and chronic
stress.
The activity of CRF2 receptors in the dRN represents a potential
neurobiological mechanism underlying the link between stress and
drug seeking. Increased serotonin release in the NAc is elicited by CRF2
receptor activation in the dRN and enhanced by stress (Lukkes et al.,
2008, 2009a). Serotonin in the NAc can, in turn, increase NAc dopa-
mine release (Fig. 2; Parsons and Justice, 1993; De Deurwaerdere et al.,
1998) and dopaminergic activity in the NAc is strongly implicated in
reward salience and drug seeking (Bardo, 1998; Tzschentke, 1998; Di
Chiara, 2002; Grace et al., 2007; Phillips et al., 2008; Floresco, 2015).
Specifically, activation of 5-HT2A and 5-HT3 receptors within the NAc
increases accumbal dopamine release likely via direct actions on do-
pamine terminals (Fig. 2), and augments associated responses to drugs
of abuse (Parsons and Justice, 1993; De Deurwaerdere et al., 1998;
Parsons et al., 1999; Bowers et al., 2000; Yan and Yan, 2001; Neumaier
et al., 2002; Alex and Pehek, 2007). While serotonin in the dopamine
cell body region of the ventral tegmental area (VTA) can enhance NAc
dopamine release either directly via 5-HT2A and 5-HT3 receptors on
dopamine neurons or via 5-HT1B receptor disinhibition via GABAergic
neurons (Fig. 2; Yan and Yan, 2001; Alex and Pehek, 2007), it is actions
of serotonin in the NAc, but not the VTA, that are critical for ser-
otonergic modulation of the rewarding effects of intracranial self-sti-
mulation and psychostimulants (Katsidoni et al., 2011). Given that
CRF2 receptor responses in the dRN are augmented after stress (Lukkes
et al., 2009a; Waselus et al., 2009; Wood et al., 2013), these converging
Fig. 2. Simplified schematic diagram illustrating how
corticotropin-releasing factor (CRF) receptor activity in
the dorsal raphe nucleus (dRN) may increase dopamine
release in the nucleus accumbens (NAc). Stressors and
drugs of abuse increase release of CRF in the dRN (a
presumptive functional CRF projection has been in-
dicated from the central nucleus of the amygdala [CeA]
and/or the bed nucleus of the stria terminalis [BNST]).
CRF activation of CRF2 receptors in the dRN appear to
increase serotoninergic neural activity and serotonin
output likely via CRF2 Gs-coupled receptor excitation
of serotonergic neurons. Resultant serotonin released in
the ventral tegmental area (VTA) can increase dopa-
mine cell firing and NAc dopamine release via activa-
tion of serotonin type 2A (5-HT2A) or type 3 (5-HT3)
receptors on dopamine neurons, or by disinhibition via
5-HT1B inhibition of inhibitory GABAergic neurons.
Furthermore, serotonin released in the NAc facilitates
dopamine release in the NAc via presynaptic 5-HT2A
and 5-HT3 receptors located on dopamine terminals.
See text for citations. Note that 5-HT2C receptors located on GABAergic neurons do not appear to play a major role in increasing mesoaccumbal dopamine release as
activation of these receptors result in hyperpolarization of dopaminergic neurons presumably via activation of GABAergic neurons, and thus reduce NAc dopamine
release (Navailles et al., 2006).
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lines of evidence suggest that drug seeking enhanced by stress may
result in part from dRN CRF2 receptor-driven serotonergic facilitation of
NAc dopamine release.
In other monoaminergic cell body regions, the stimulatory effects of
CRF2 receptors appear to be related to the presence or activity of the
CRF binding protein (CRF-BP). While traditionally thought of as a ‘li-
gand-sink’ (Jahn et al., 2005), the CRF-BP is necessary for CRF2 re-
ceptor-mediated potentiation of NMDA-induced activation of dopamine
neurons in the VTA (Ungless et al., 2003) and plays an important role in
stress-induced reinstatement of cocaine self-administration that is de-
pendent on CRF2 receptor activation in the VTA (Wang et al., 2007).
Therefore, it has been suggested that the CRF-BP may play a permissive
role in CRF's actions at the CRF2 receptor in the VTA (Ungless et al.,
2003). Moreover, the CRF-BP promotes trafficking of CRF2α receptors
(neural CRF2 receptors) to the cellular membrane in cultured me-
sencephalic neurons (Slater et al., 2016). Whether the CRF-BP plays
similar roles in the dRN is an important future direction, as the CRF-BP
may provide a novel pharmacological target to manipulate CRF2 re-
ceptor function and trafficking in the dRN following early-life adversity.
5. Ontogeny and sexual dimorphism of CRF-Serotonin systems
The CRF system, with its influence on monoaminergic function in
the brain, is well positioned to be affected by stressors from early in life
and throughout maturation (Fig. 1), with potential long-term con-
sequences for later drug-related behaviors. This is because CRF ex-
pression peaks early in development (PND 8) within the paraventricular
nucleus of the hypothalamus (PVN), and later in other brain regions
such as the hippocampus (PND 18) (Chen et al., 2001; Korosi and
Baram, 2008). An exception to this is CRF expression in the CeA, which
appears to increase over the course of development alongside in-
creasing expression of the CRF-BP in this region (Vazquez et al., 2006).
Given that one target of CRF afferents from the CeA is likely the dRN
(Gray, 1993), this latter finding provides the intriguing possibility that
CRF innervation of, or CRF activity in the dRN similarly increases over
maturation and could be more susceptible to perturbation over a longer
developmental period than other neural CRF systems.
The expression of CRF receptors in the brain initially was also
thought to peak very early in development, with rat whole brain
homogenates showing increases from birth to peak at PND 8, declining
thereafter through the rest of development (Insel et al., 1988). In a si-
milar timeframe, CRF receptor mRNA expression peaks between PND
2–9 in the hippocampus, amygdala, and cortex (Avishai-Eliner et al.,
1996). However, when studies have included later developmental time
points and examined both sexes, clear pre- and post-pubertal sex dif-
ferences emerge for CRF receptor ontogeny that are often receptor and
brain region specific. For example, CRF1 receptor expression is similar
among male and female pre-pubertal rats in the amygdala, but de-
creases in males and increases in females after puberty (measured in
adulthood at PND 98; Weathington et al., 2012, 2014). Of the variety of
corticolimbic brain regions studied, each with their own sex- and age-
dependent changes in CRF1 receptor expression, a general pattern of
greater CRF1 receptor expression in post-pubertal females emerges
(Weathington et al., 2012, 2014). In contrast, amygdala CRF2 receptor
expression is higher in adult males because of an increase in CRF2 re-
ceptor expression over adolescence that is absent in females
(Weathington et al., 2012, 2014). Greater CRF2 receptor expression in
males also holds true for many other limbic brain regions (Weathington
et al., 2014). Overall, there appears to be a sex difference in CRF1/2
receptor expression in the post-pubertal brain as a result of differential
maturation patterns. Males have greater CRF2 receptor expression as
adults whereas females exhibit greater expression of anxiogenic CRF1
receptors throughout adolescence. These latter findings suggest a pos-
sible mechanism for higher incidence of anxiety disorders in females
(Weathington et al., 2012).
Only one study to date (Lukkes et al., 2016) has explored the
ontogeny and sexual dimorphism of CRF receptors within the dRN, and
currently no information regarding sex-dependent expression or the
developmental trajectory of the CRF-BP in the dRN is available. Overall,
there is very little developmental change in either CRF1 or CRF2 mRNA
in the dorsal and ventrolateral subregions of dRN from early adoles-
cence (PND 25) to adulthood (PND 90) (Lukkes et al., 2016). Earlier
ages were not examined, leaving the possibility that CRF receptor ex-
pression in the dRN, like other brain regions (e.g., Insel et al., 1988;
Avishai-Eliner et al., 1996), peaks very early in development. However,
like other brain regions, clear sex differences in CRF receptor expression
are apparent in subregions of the dRN that project to the cortex and
NAc (Lukkes et al., 2016). In contrast to other brain regions discussed
earlier, CRF2 receptor mRNA expression in the dorsal ventrolateral dRN
is higher in females compared to males (Lukkes et al., 2016). Whether
this results in a change of the net activity of the dRN to affect ser-
otonergic output to the limbic system in a sex-specific manner is not
known, but if this is the case, it may help explain the increased risk for
females in the development of stress psychopathology, including stress-
induced drug relapse (Sinha et al., 2007; Ter Horst et al., 2009; Hudson
and Stamp, 2011; Becker et al., 2012).
The exact mechanisms underlying sexual dimorphism of CRF re-
ceptor expression are not understood, but sex steroids may play an
important role given the greater divergence in expression in post-pub-
ertal animals (Weathington et al., 2012, 2014; Lukkes et al., 2016). For
instance, non-aromatizable androgen administration to castrated male
rats increases CRF2 mRNA in a variety of limbic structures (Weiser
et al., 2008). This effect aligns with the natural pattern of higher CRF2
receptor expression in the same limbic regions of the male brain
(Weathington et al., 2012, 2014), and suggests that such heightened
CRF2 receptor expression in post-pubertal males is mediated by an-
drogens or androgenic metabolites such as dihydrotestosterone and 3α-
andronstanediol. However, it is unclear how such findings relate to the
contrasting higher expression of CRF2 mRNA in the dorsal ventrolateral
dRN of females (Lukkes et al., 2016), especially as only male rats and
mice express androgen receptors in the dRN (Sheng et al., 2004). Al-
ternatively, the pattern seen in the dRN of females may reflect actions
of estrogenic steroids, receptors for which are also located in the rodent
dRN (Sheng et al., 2004). Support for an estrogen-mediated effect
comes from studies showing that estradiol upregulates CRF2 receptor
mRNA expression in the dRN of nonhuman primates (Sanchez et al.,
2010; Bethea et al., 2015), possibly via demethylation of the CRF2 re-
ceptor gene promoter that has been observed in myocardial cells (Cong
and Ni, 2014). Further research that examines the effects of sex steroids
on both CRF receptor types in a variety of limbic and monoamine cell
body brain regions will clarify a potential and differential role for these
hormones in the sexually dimorphic pattern observed over later de-
velopment.
In addition to sex differences in total cell expression of CRF re-
ceptors, differences between males and females in CRF receptor cell
surface expression, receptor trafficking and G-protein coupling have
been documented (Bangasser et al., 2010, 2013; Valentino et al., 2012;
Bangasser, 2013). For example, female rats show greater coupling of
cortical CRF1 receptor-Gs protein coupling in control conditions,
whereas stress increases this coupling in male rats to female stress-naïve
levels, and has no effect in females (Bangasser et al., 2010). Further-
more, stress enhances the association between cortical CRF1 receptors
and β-arrestin2 (necessary for receptor internalization) in males only
(Bangasser et al., 2010). The sex difference in β-arrestin2 association
with CRF1 receptors is in line with observations of CRF-induced or
stress-induced internalization of CRF receptors in the locus coeruleus
(LC) of males and recruitment of CRF receptors to the cellular mem-
brane in the LC of females (Bangasser et al., 2010, 2013). Similarly,
proestrus female rats exhibit higher membrane localization of CRF1/2
receptors in hippocampal dendrites compared to males (Williams et al.,
2011), suggestive of differential CRF receptor trafficking in the hippo-
campus among the sexes. Interestingly, there appears to be little role of
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ovarian steroids since ovariectomy does not alter the coupling or traf-
ficking of CRF receptors in the cortex or LC of females (Bangasser et al.,
2010). Overall, it appears that increased sensitivity of neurons in the
female brain to CRF (Bangasser et al., 2010, 2013; Bangasser, 2013)
may result from increased coupling to Gs proteins, and that sex dif-
ferences in stress responses and stress-related psychiatric illness could
be explained by differential effects of stress on CRF receptor coupling
and trafficking (Valentino et al., 2012, 2013; Bangasser, 2013). While
stress-induced receptor trafficking is certainly an important phenom-
enon in the dRN (Waselus et al., 2009; Wood et al., 2013), it remains to
be seen whether there are sex differences in CRF receptor coupling or
trafficking in this serotonergic region.
Like CRF receptor expression, TPH2 mRNA expression is sexually
dimorphic, with levels increasing throughout adolescence in males, but
peaking at PND 42 in females before declining into adulthood (Lukkes
et al., 2016). Since TPH2 mRNA expression reflects TPH2 levels in
neurons (Bach et al., 2014), the latter finding strongly suggests differ-
ential serotonergic activity in the dorsal ventrolateral dRN in males and
females over late adolescence that may help explain sexually dimorphic
outcomes in response to stress exposure during this time (Burke et al.,
2017). In contrast to the lack of change in CRF receptor expression
across adolescence in the dRN discussed earlier, tryptophan hydro-
xylase 2 (TPH2; an isozyme of the rate-limiting enzyme of serotonin
synthesis) mRNA expression increases in the dorsal ventrolateral dRN,
suggesting increased serotonergic activity over development (Lukkes
et al., 2016). This pattern mirrors the increase in serotonin and its
metabolite 5–hydroxyindoleacetic acid (5-HIAA) that is observed in
limbic and brainstem structures up until at least mid-adolescence (PND
45) (Chen et al., 1997).
Overall, the earlier developmental processes characterizing the CRF
system, combined with later sex-specific maturation of CRF receptors
and serotonergic activity, places CRF interactions with the serotonergic
dRN in a prime position to be affected by stressors from very early
postnatal development to at least mid-adolescence (Fig. 1). Therefore,
dysfunction of CRF-serotonin interactions at the level of the dRN may
represent an important neural mechanism by which early-life adversity
increases the risk for drug-associated problems later in life.
6. Early-life adversity alters CRF-Serotonin interactions and drug-
related behaviors
Early-life adversity exerts effects on CRF and serotonergic signaling
in mesolimbic reward circuitry that can persist into adulthood (Plotsky
et al., 2005; Miczek et al., 2008; Lukkes et al., 2009c; Burke and
Miczek, 2014), with deleterious consequences for reward processing
and goal-directed behavior. For example, peri-adolescent social stress
(social isolation/disruption or social defeat) has been shown to upre-
gulate CRF2 receptors in the lateral dRN of adult male rats (Lukkes
et al., 2009a; Bledsoe et al., 2011, Fig. 3A and B). This effect is specific
to CRF2 receptors, as expression and activity of CRF1 receptors in the
adult dRN is not altered by either peri-adolescent stressor (Lukkes et al.,
2009a; Bledsoe et al., 2011, Fig. 3A and B). Moreover, the upregulation
of CRF2 receptors in rats defeated in adolescence is only evident in the
dRN, and is not seen in either the VTA or the locus coeruleus (LC,
Fig. 3C). Increased CRF2 receptors in the lateral dRN following peri-
adolescent stress results in prolonged CRF2-induced serotonin release in
the NAc core in adulthood (Lukkes et al., 2009a). As described earlier,
increased serotonin in the NAc facilitates dopamine release in this re-
gion via direct actions on serotonin receptors (Fig. 2), and augments
responses to drugs of abuse (Parsons and Justice, 1993; Parsons et al.,
1999; Neumaier et al., 2002; Alex and Pehek, 2007). Drugs of abuse
also activate extrahypothalamic CRF neurons and increase CRF levels in
the brain (Sarnyai et al., 1993; Richter and Weiss, 1999; Zorrilla et al.,
2014). Thus, drug- or stress-induced increases in CRF2 receptor acti-
vation in the dRN following peri-adolescent stress, and the influence of
this on accumbal serotonin and dopamine, represents a neural substrate
linking stress experience during adolescence with increased drug re-
sponsivity and drug seeking later in life. It should be noted that the
studies to date have been performed exclusively in male rodents. As
discussed earlier, females have greater CRF2 receptor mRNA expression
and also higher TPH2 mRNA levels in the dorsal ventrolateral dRN
(Lukkes et al., 2016) that could play an important role in sexually-di-
morphic responses to early-life adversity. However, neither the effects
of social isolation nor defeat on CRF receptors in the dRN and resultant
accumbal monoaminergic activity have been determined for females.
Enhanced CRF2 receptor-serotonin interactions at the level of the
dRN may not only increase drug-seeking behaviors, but also the
Fig. 3. Corticotropin-releasing factor (CRF) receptor expression in mono-
aminergic cell body regions was measured from adult male rats (PND 60) using
methods described by Lukkes et al. (2009a). Rats were exposed to either ado-
lescent social defeat or control handling conditions from PND 35–39, as de-
tailed by Watt et al. (2009) – a paradigm known to increase cocaine and am-
phetamine responses in adulthood (Burke et al., 2011, 2013, 2016; Burke and
Miczek, 2015). A) Representative Western blot images of CRF2 receptor, CRF1
receptor, and actin (loading control) expression in the dorsal raphe nucleus
(dRN). B) CRF2, but not CRF1 receptor expression was increased in the dRN of
adult male rats exposed to adolescent social defeat. C) No changes in either
CRF1 or CRF2 receptor expression was observed in the ventral tegmental area
(VTA) or locus coeruleus (LC) in adult male rats exposed to adolescent social
defeat. #P < 0.05 compared to controls. All data represented as mean va-
lues + S.E.M. N = 20 per group.
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negative affect commonly associated with drug withdrawal and relapse
(Koob et al., 2013). Selective antagonism of CRF2, but not CRF1 re-
ceptors globally in the dRN, prevents anxiety-like behaviors of adult
rats exposed to adolescent social isolation/disruption and those un-
dergoing amphetamine withdrawal (Lukkes et al., 2009b; Vuong et al.,
2010; Bledsoe et al., 2011). Therefore, increased expression of CRF2
receptors in the dRN following peri-adolescent social stress may have
important consequences for negative affect-induced reinstatement of
drug seeking in individuals exposed to early-life adversity.
In contrast to social isolation/disruption and defeat, maternal se-
paration decreases CRF2 receptor expression while CRF1 receptor
mRNA is increased in the adult dRN (Bravo et al., 2011). This difference
in CRF receptor mRNA expression may be a function of the earlier
developmental time period in which maternal separation is applied,
corresponding to the greatest change in CRF receptor expression over
development (Fig. 1). If these alterations to CRF receptor mRNA are
translated to receptor expression and function, this would result in re-
duced accumbal serotonin and dopamine responses to stress and drugs
of abuse (Fig. 2). On the other hand, dRN serotonergic neurons in adult
rats are more responsive to stress (Pollano et al., 2017) and prolonged
maternal separation increases the number of serotonin neurons and the
capacity for serotonin synthesis (as reflected by TPH mRNA) in the
ventrolateral subregion of the rat dRN in adulthood (Gardner et al.,
2009; van der Doelen et al., 2017). This is important because it is the
ventrolateral subregion of the dRN that innervates the NAc (Van
Bockstaele et al., 1993), allowing the potential for greater serotonergic
responses in the NAc following maternal separation. Maternal separa-
tion has been shown to alter serotonin signaling in the NAc, but results
can be conflicting. Male rats exhibit either decreased (Oreland et al.,
2011) or increased (Xue et al., 2013) basal NAc serotonin tissue content
in adulthood, while acute stress-induced increases in the serotonergic
metabolite 5-HIAA within the NAc of middle-aged (15 month) female
rats is exacerbated by maternal separation (Arborelius and Eklund,
2007). In line with reduced CRF2 receptor expression (and presumably
attenuated facilitation of dopamine in the NAc), adult rats that ex-
perienced maternal separation exhibit blunted NAc dopamine release in
response to food rewards either before or following chronic mild stress
(Minami et al., 2017; Romani-Perez et al., 2017). More aligned with
enhanced sensitivity of dRN neurons and greater serotonergic in-
nervation of the NAc, maternal separation augments the accumbal
dopaminergic response to both acute amphetamine (Hall et al., 1999)
and acute stress (Brake et al., 2004) in adulthood. These contrasting
findings may be reconciled by a reward deficiency syndrome which is
hypothesized to underlie greater drug seeking following maternal se-
paration (Delavari et al., 2016). This syndrome may reflect both dam-
pened tonic and heightened phasic serotonin release in the NAc, re-
spectively resulting in deficient accumbal dopamine to cause a blunted
hedonic state that encourages initial drug taking (Wand, 2008), but
augmented stress-induced dopamine release that would promote drug
seeking during abstinence.
Epigenetic processes have emerged as a critical mediator between
genes and postnatal environment in conferring risk for later emergence
of neuropsychiatric disorders, including addiction (see Cadet, 2016;
Ajonijebu et al., 2017 for recent reviews). In brief, these processes
broadly encompass changes to gene expression that are not secondary
to alterations in DNA sequences (Jablonka, 2012). Among the most well
studied epigenetic processes are chromatin histone acetylation, which
typically promotes gene expression and methylation either of histones
or of DNA cytosine-guanine dinucleotide (CpG) sites to result in re-
pression of gene transcription (Smith and Meissner, 2013; Guintivano
and Kaminsky, 2016). Of relevance, maternal separation in rats has
been shown to cause both increased acetylation and hypomethylation
of the Crf promoter in the adult hippocampus and hypothalamus,
leading to increased expression of CRF mRNA and protein (Chen et al.,
2012; Wang et al., 2014). Maternal separation has also been shown to
increase CRF mRNA specifically in the dRN (Bravo et al., 2011).
Therefore, neonatal stress-induced epigenetic modifications resulting in
increased CRF in the dRN may explain downregulation of the CRF2
receptor in rats exposed to maternal separation (Bravo et al., 2011),
given that ligand and receptor availability are often inversely related
(as discussed by Weathington et al., 2014). Moreover, CRF-related
epigenetic modifications induced by maternal separation are found in
first and second generation male and female offspring (Franklin et al.,
2010). While more studies in this area are necessary, these findings
highlight the possibility that the negative consequences of early-life
adversity may be transmitted to subsequent generations via epigenetic
modifications of neural CRF systems.
To date, epigenetic effects of peri-adolescent stress on either CRF or
CRF receptors do not appear to have received much attention, with
most studies examining the influence of stress exposure earlier in
postnatal life. Hypomethylation at multiple CpG sites of the Crf2 pro-
moter, which results in greater promoter activity indicating disinhibi-
tion of gene expression, has been observed in otherwise healthy in-
dividuals who report higher generalized anxiety (Schartner et al.,
2017). This phenotype is reminiscent of increased anxiety and in-
creased CRF2 receptor expression in the dRN of adult rats exposed to
social isolation/disruption during adolescence (Lukkes et al., 2009a; b;
Bledsoe et al., 2011). As such, it is tempting to speculate that long-term
upregulation of CRF2 receptor expression in the dRN as observed fol-
lowing early-life adversity (Lukkes et al., 2009a, Fig. 3) may result from
reduced methylation of the Crf2 gene, but this is yet to be determined. If
true, it may have implications for understanding sex differences in
behavioral responses to abused substances following early-life (parti-
cularly adolescent) adversity, given that adolescent female rats show a
10-fold higher expression of CRF2 mRNA in the dRN compared to males
(Lukkes et al., 2016). This sex specific ontogeny could conceivably in-
crease susceptibility of females to stress-induced changes in epigenetic
regulation of the CRF2 receptor, with detrimental consequences for
serotonergic and dopaminergic signaling in reward pathways.
7. Conclusions
Both human and preclinical studies clearly demonstrate that early-
life adversity is associated with a greater propensity for substance abuse
in later life. Converging evidence suggests that this may be in part due
to alterations of CRF2 receptors in the dRN following early-life adver-
sity, which have the ability to promote long-lasting alterations to ac-
cumbal monoaminergic transmission and related behaviors. While
heightened drug- and alcohol-related behaviors appear similar between
pre-adolescent stress (e.g. maternal separation) and stressors later in
peri-adolescent development (e.g. social isolation/disruption and social
defeat), underlying mechanisms may differ with opposite effects on
CFR2 receptor expression and activity within the mesolimbic system.
Regardless, the CRF2 receptor may represent a pharmacotherapeutic
target for reducing the negative consequences of early-life adversity,
but translational studies are hampered by the lack of CRF2 receptor
antagonists that effectively cross the blood-brain barrier (Forster et al.,
2012; Vinzant et al., 2017). Recent progress in nanomaterials have been
employed to facilitate CRF2 receptor ligands crossing the blood-brain
barrier to have efficacy at the level of the dRN (Vinzant et al., 2017),
increasing the promise of the CRF2 receptor as a novel target for re-
ducing the impact of early-life adversity. However, advancements in
preventing and treating substance dependence associated with early-
life adversity will continue to be hampered by a paucity of neurobio-
logical studies within preclinical female models. Future work should be
directed at understanding sex differences in CRF-serotonin interactions
within the dRN and how sexually dimorphic expression of CRF re-
ceptors in the dRN, and in dRN serotonin development, translate to
greater vulnerability of women to be negatively affected by early-life
adversity.
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